Jikei University School of Medicine, Tokyo, Japan.
Diabetes Res Clin Pract. 2013 May;100(2):e31-3. doi: 10.1016/j.diabres.2013.02.003. Epub 2013 Mar 19.
To investigate the role of HDL-C in cardiovascular risk reduction, we evaluated using data from a diabetic population in a large clinical trial with pravastatin. A significant risk reduction in CVD was found only in diabetic patients who had both a reduction in LDL-C and an increase in HDL-C.
为了研究 HDL-C 在降低心血管风险中的作用,我们使用来自大型临床试验中使用普伐他汀的糖尿病患者的数据进行了评估。仅在 LDL-C 降低和 HDL-C 升高的糖尿病患者中发现 CVD 风险显著降低。